Cargando…

Beclin1 circulating levels and accelerated aging markers in COPD

Detalles Bibliográficos
Autores principales:	Schlemmer, Frédéric, Boyer, Laurent, Soumagne, Thibaud, Ridoux, Audrey, Chouaid, Christos, Maitre, Bernard, Lanone, Sophie, Adnot, Serge, Audureau, Etienne, Boczkowski, Jorge
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833829/ https://www.ncbi.nlm.nih.gov/pubmed/29402890 http://dx.doi.org/10.1038/s41419-017-0178-1

Ejemplares similares

Are Systemic Manifestations Ascribable to COPD in Smokers? A Structural Equation Modeling Approach
por: Boyer, Laurent, et al.
Publicado: (2018)

Aging-Related Systemic Manifestations in COPD Patients and Cigarette Smokers
por: Boyer, Laurent, et al.
Publicado: (2015)

Early signs of multi-walled carbon nanotbues degradation in macrophages, via an intracellular pH-dependent biological mechanism; importance of length and functionalization
por: Landry, Marion, et al.
Publicado: (2016)

Macrophage autophagy protects mice from cerium oxide nanoparticle-induced lung fibrosis
por: Annangi, Balasubramanyam, et al.
Publicado: (2021)

The telomerase activator TA-65 protects from cigarette smoke-induced small airway remodeling in mice through extra-telomeric effects
por: Tiendrébéogo, Arnaud Jean Florent, et al.
Publicado: (2023)

Substantial modification of the gene expression profile following exposure of macrophages to welding-related nanoparticles
por: Audureau, Étienne, et al.
Publicado: (2018)

Air pollution as an early determinant of COPD
por: Lu, Zhuyi, et al.
Publicado: (2022)

Impact of triple therapy on mortality in COPD
por: Soumagne, Thibaud, et al.
Publicado: (2023)

Immune response to pertussis vaccine in COPD patients
por: Feredj, E., et al.
Publicado: (2023)

Significance of Stenotrophomonas maltophilia When Detected in Sputum of Ambulatory Patients with COPD
por: Soumagne, Thibaud, et al.
Publicado: (2021)

GPs should not try to detect mild COPD
por: Enright, Paul, et al.
Publicado: (2020)

Effective respiratory management of asthma and COPD and the environmental impacts of inhalers
por: Usmani, Omar S., et al.
Publicado: (2023)

Autophagy as a Possible Underlying Mechanism of Nanomaterial Toxicity
por: Cohignac, Vanessa, et al.
Publicado: (2014)

Short-Term Oxygen Therapy Outcomes in COPD
por: Soumagne, Thibaud, et al.
Publicado: (2022)

A plan for accelerated action on obesity
por: Branca, Francesco, et al.
Publicado: (2023)

COPD’s early origins in low-and-middle income countries: what are the implications of a false start?
por: Brakema, E. A., et al.
Publicado: (2019)

In Patients with Mild-to-Moderate COPD, Tobacco Smoking, and Not COPD, Is Associated with a Higher Risk of Cardiovascular Comorbidity
por: Soumagne, Thibaud, et al.
Publicado: (2020)

Canada and global health: accelerate leadership now
por: Evans, Timothy G
Publicado: (2018)

COVID-19 and the global acceleration of digital psychiatry
por: Stein, Dan J, et al.
Publicado: (2022)

Accelerate investment and action to find the missing patients with tuberculosis
por: Dheda, Keertan, et al.
Publicado: (2022)

Anxiety and depression among dairy farmers: the impact of COPD
por: Guillien, Alicia, et al.
Publicado: (2017)

Circulating ACE2: a novel biomarker of cardiovascular risk
por: Ramchand, Jay, et al.
Publicado: (2020)

Deeper, longer phenotyping to accelerate the discovery of the genetic architectures of diseases
por: Kohane, Isaac S
Publicado: (2014)

Accelerating genomics-based surveillance for COVID-19 response in Africa
por: Tessema, Sofonias K, et al.
Publicado: (2020)

Can COVID-19 help accelerate and transform the diagnostics agenda?
por: Kleinert, Sabine, et al.
Publicado: (2021)

Accelerating CO(2) electrochemical conversion towards industrial implementation
por: Segets, Doris, et al.
Publicado: (2023)

Designing circulating tumor DNA-based interventional clinical trials in oncology
por: Araujo, Daniel V., et al.
Publicado: (2019)

Growth-coupled selection of synthetic modules to accelerate cell factory development
por: Orsi, Enrico, et al.
Publicado: (2021)

Global coalition to accelerate COVID-19 clinical research in resource-limited settings
Publicado: (2020)

A conceptual framework to accelerate the clinical impact of evolving research into long COVID
por: Kondratiuk, Alexandra L, et al.
Publicado: (2021)

Approvals in 2021: dangling Accelerated Approvals, drug dosing, new approvals and beyond
por: Lemery, Steven, et al.
Publicado: (2022)

Accelerating towards net zero emissions: the most important global health intervention
por: Fu-Chun, Margaret Chan Fung
Publicado: (2021)

Accelerating measles elimination in the Western Pacific Region during the calm between the storms
por: Durrheim, David N., et al.
Publicado: (2022)

Human papillomavirus vaccination strategies for accelerating action towards cervical cancer elimination
por: Shet, Anita, et al.
Publicado: (2023)

Leadership training to accelerate progress in public health in sub-Saharan Africa: time for action
por: Manabe, Yukari C, et al.
Publicado: (2020)

Imperative to accelerate research aligning real-time clinical demand with mental health supply
por: Zima, Bonnie T., et al.
Publicado: (2022)

Pulmonary acceleration time to optimize the timing of lung transplant in cystic fibrosis
por: Damy, Thibaud, et al.
Publicado: (2012)

Impact of interleukin-6 on hypoxia-induced pulmonary hypertension and lung inflammation in mice
por: Savale, Laurent, et al.
Publicado: (2009)

Neutralizing antibodies and their cocktails against SARS-CoV-2 Omicron and other circulating variants
por: Yang, Yang, et al.
Publicado: (2022)

Accelerating evidence gathering and approval of precision medicine therapies: the FDA takes aim at rare mutations
por: Issa, Amalia M., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_hckj6hc92osd8c8lafnkpmfk7r